InvestorsHub Logo

longfellow95

07/23/16 4:41 PM

#67329 RE: maverick_1 #67327

Mav

Scroll down Day 2 programme. Linda is chairing the plenary session commencing at 16.25. This is the last session of the entire conference.
So she will effectively be doing the concluding remarks.

And she is on the the Immunotherapy Advisory Board along with senior guys from Pfizer, GSK, and Merck.

Sort of elevates her to the position of accepted insider. Different from previously.

md1225

07/23/16 4:48 PM

#67330 RE: maverick_1 #67327

I told everyone here the deal is already done with BMY....

It will not be announced till after the FDA say enrollment may commence...

There's upfront money too .... I have no idea how much.

Signed in March will take four months to have trial sites up and trained...

Last I heard TBA as soon as the FDA says go...

Monday?

August?